{"id":43599,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/series-c-stock-purchase-agreement.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"series-c-stock-purchase-agreement","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/planning\/series-c-stock-purchase-agreement.html","title":{"rendered":"Series C Stock Purchase Agreement"},"content":{"rendered":"<pre>                            BAM! ENTERTAINMENT, INC.\n\n                        SERIES C STOCK PURCHASE AGREEMENT\n\n                                  MAY 24, 2001\n\n\n\n   2\n\n                                    EXHIBITS\n\n<\/pre>\n<table>\n<s>             <c><br \/>\nExhibit A       &#8211;   Second Amended and Restated Certificate of Incorporation<br \/>\nExhibit B       &#8211;   Registration Rights Agreement<br \/>\nExhibit C       &#8211;   Proprietary Information and Inventions Agreement<br \/>\nExhibit D       &#8211;   Bylaws of the Company<br \/>\nExhibit E       &#8211;   Opinion of Counsel to the Company<br \/>\nExhibit F       &#8211;   Co-Sale and Right of First Refusal Agreement<br \/>\n<\/c><\/s><\/table>\n<p>                                    SCHEDULES<\/p>\n<table>\n<s>                  <c><br \/>\nSchedule 1           &#8211;     Schedule of Purchasers<br \/>\nSchedule 2.2(a)      &#8211;     Contingent Reserved Common Shares<br \/>\nSchedule 2.2(d)      &#8211;     Stockholders and Option Holders List<br \/>\nSchedule 2.3         &#8211;     Subsidiaries<br \/>\nSchedule 2.7         &#8211;     Litigation<br \/>\nSchedule 2.8(a)      &#8211;     Material Intellectual Property<br \/>\nSchedule 2.8(b)      &#8211;     Certain IP Agreements<br \/>\nSchedule 2.10        &#8211;     Material Agreements<br \/>\nSchedule 2.10(b)     &#8211;     Nonbinding Contracts<br \/>\nSchedule 2.11        &#8211;     Liabilities<br \/>\nSchedule 2.13        &#8211;     Conflicts<br \/>\nSchedule 2.17        &#8211;     Employee Benefit Plans<br \/>\nSchedule 2.24        &#8211;     Financial Statements<br \/>\nSchedule 2.25(d)     &#8211;     Changes; Contracts\/Agreements<br \/>\nSchedule 2.25(e)     &#8211;     Changes; Compensation\/Agreements with employees,<br \/>\n                           representatives, agents, officers, directors or stockholders<br \/>\nSchedule 2.25(i)     &#8211;     Changes; Loans\/Guarantees<br \/>\n<\/c><\/s><\/table>\n<p>   3<\/p>\n<p>                        SERIES C STOCK PURCHASE AGREEMENT<\/p>\n<p>        THIS STOCK PURCHASE AGREEMENT (this &#8220;Agreement&#8221;), dated as of May 24,<br \/>\n2001, is entered into by and among BAM! Entertainment, Inc., a Delaware<br \/>\ncorporation (with its predecessors and successors, the &#8220;Company&#8221;), and the<br \/>\nparties listed on Schedule 1 hereto (each, individually, a &#8220;Purchaser&#8221; and,<br \/>\ncollectively, the &#8220;Purchasers&#8221;).<\/p>\n<p>                                   WITNESSETH:<\/p>\n<p>        A. The Company, successor in interest to Bay Area Multimedia, Inc., a<br \/>\nCalifornia corporation, was formerly known as Bay Area Multimedia, Inc., a<br \/>\nDelaware corporation.<\/p>\n<p>        B. Subject to the terms and conditions set forth herein, the Company<br \/>\ndesires to issue and sell to the Purchasers, and the Purchasers severally desire<br \/>\nto purchase from the Company, shares of the Company&#8217;s Series C Preferred Stock,<br \/>\npar value $0.001 per share, for an aggregate purchase price of up to<br \/>\n$10,000,000, as partially set forth on Schedule 1 attached hereto.<\/p>\n<p>        C. The Purchasers and the Company desire to set forth their mutual<br \/>\nagreements with respect to such purchase and sale and to establish various<br \/>\nrights and obligations in connection therewith.<\/p>\n<p>        NOW, THEREFORE, in consideration of the premises and the mutual<br \/>\ncovenants contained herein and other good and valuable consideration, the<br \/>\nreceipt and sufficiency of which are hereby acknowledged, the parties agree as<br \/>\nfollows:<\/p>\n<p>        1. Purchase and Sale of Preferred Stock..<\/p>\n<p>                1.1 Sale and Issuance of Series C Preferred Stock.<\/p>\n<p>                        (a) The Company shall adopt and file with the Secretary<br \/>\nof State of the State of Delaware on or before the Closing (as defined below)<br \/>\nthe Amended and Restated Certificate of Incorporation of the Company in the form<br \/>\nattached hereto as Exhibit A (the &#8220;Restated Certificate&#8221;).<\/p>\n<p>                        (b) Subject to the terms and conditions of this<br \/>\nAgreement, each Purchaser severally (but not jointly) agrees to purchase at the<br \/>\nClosing, and the Company agrees to sell and issue to such Purchaser at the<br \/>\nClosing, such number of shares of the Company&#8217;s Series C Preferred Stock, par<br \/>\nvalue $0.001 per share, as set forth opposite such Purchaser&#8217;s name on Schedule<br \/>\n1 attached hereto, at a purchase price of $22.553 per share, and for the total<br \/>\npurchase price indicated with respect to such Purchaser on Schedule 1,<br \/>\nrepresenting an aggregate purchase price of up to $10,000,000 for all<br \/>\nPurchasers. The shares of Series C Preferred Stock to be issued to the<br \/>\nPurchasers pursuant to this Agreement shall hereinafter be referred to as the<br \/>\n&#8220;Series C Preferred Stock.&#8221;<\/p>\n<p>                1.2 Closing; Delivery. The closing of the purchase and sale of<br \/>\nthe Series C Preferred Stock (the &#8220;Closing&#8221;) shall take place at one or more<br \/>\nclosings. All Closings shall be held at the offices of Doty Sundheim &amp; Gilmore,<br \/>\n260 Sheridan Avenue, Suite 200, Palo Alto,<\/p>\n<p>                                       1<br \/>\n   4<\/p>\n<p>California. The first Closing shall occur at 9:00 a.m. Pacific Standard Time on<br \/>\nMay 4, 2001, or at such other time and place as the Company and the Purchasers<br \/>\nmutually agree upon, orally or in writing (the &#8220;Initial Closing&#8221; and the<br \/>\n&#8220;Closing Date&#8221;). The subsequent Closings shall occur at such times as approved<br \/>\nof by the parties to such Closing. At each Closing, the Company shall deliver to<br \/>\neach Purchaser a certificate registered in the name of such Purchaser<br \/>\nrepresenting the Series C Preferred Stock being purchased thereby against<br \/>\npayment of the purchase price therefor, which shall be payable by check or by<br \/>\nwire transfer of immediately available funds to an account designated by the<br \/>\nCompany. The Company and each Purchaser shall take such additional actions and<br \/>\nexecute and deliver such additional agreements and other instruments and<br \/>\ndocuments as may be reasonably necessary or appropriate to effect the<br \/>\ntransactions contemplated by this Agreement in accordance with its terms.<\/p>\n<p>                1.3 Use of Proceeds. The Company shall apply the proceeds<br \/>\nreceived hereunder from the sale of the Series C Preferred Stock to pay for the<br \/>\nreasonable expenses of the Company associated with the issuance of the Series C<br \/>\nPreferred Stock, to fund continued product and service development, to fund a<br \/>\nbroader market launch of the Company&#8217;s services, to build corporate<br \/>\ninfrastructure and for general working capital purposes.<\/p>\n<p>                1.4 Reservation of Additional Shares of Series C Preferred<br \/>\nStock. As set forth in the Restated Certificate, the Company has reserved a<br \/>\ntotal of 443,400 shares of its Series C Preferred Stock, par value $0.001 per<br \/>\nshare, for issuance and sale pursuant to this Agreement.<\/p>\n<p>        2. Representations, Warranties and Covenants of the Company. The Company<br \/>\nhereby represents and warrants to, and covenants with, each of the Purchasers,<br \/>\nas follows:<\/p>\n<p>                2.1 Organization, Good Standing and Qualification. The Company<br \/>\nis a corporation duly organized, validly existing and in good standing under the<br \/>\nlaws of the State of Delaware and has all requisite corporate power and<br \/>\nauthority to carry on its business as now conducted and to execute, deliver and<br \/>\nperform this Agreement, the &#8220;Co-Sale and Right of First Refusal Agreement&#8221; and<br \/>\nthe &#8220;Registration Rights Agreement&#8221; (as defined in Section 2.4 below)<br \/>\n(collectively, the &#8220;Transaction Agreements&#8221;), and to carry out the transactions<br \/>\ncontemplated by each of the Transaction Agreements. The Company is duly<br \/>\nqualified to transact business and is in good standing in the State of<br \/>\nCalifornia and in each other jurisdiction in which the failure to be so<br \/>\nqualified would have a material adverse effect on the business (as now<br \/>\nconducted), financial or other condition, operating results, assets or<br \/>\nproperties of the Company (each such effect, a &#8220;Material Adverse Effect&#8221;).<\/p>\n<p>                2.2 Capitalization. The authorized capital stock of the Company<br \/>\nconsists, or will consist, immediately prior to the Closing, of:<\/p>\n<p>                        (a) 10,000,000 shares of common stock, par value $0.001<br \/>\nper share (the &#8220;Common Stock&#8221;), of which 327,385 shares are issued and<br \/>\noutstanding. All of the issued and outstanding shares of Common Stock have been<br \/>\nduly authorized, are fully-paid and nonassessable and were issued in compliance<br \/>\nwith all applicable federal and state securities laws. The Company has reserved<br \/>\n976,220 shares of Common Stock for issuance upon conversion of the Series A<br \/>\nPreferred Stock (as defined below), 320,000 shares of Common Stock for issuance<br \/>\nupon conversion of the Company&#8217;s Series B Preferred Stock, par value $0.001 per<br \/>\nshare, 443,400<\/p>\n<p>                                       2<br \/>\n   5<br \/>\nshares of Common Stock for issuance upon conversion of the Company&#8217;s Series C<br \/>\nPreferred Stock, par value $0.001 per share, 325,000 shares of Common Stock for<br \/>\nissuance pursuant to the exercise of options issued or reserved for issuance<br \/>\nunder stock incentive plans currently effective (the &#8220;Stock Plan&#8221;), 43,500<br \/>\nshares of Common Stock for issuance upon exercise of warrants to purchase Common<br \/>\nStock issued to PAR Capital (30,000 shares), K&amp;L 2000 LLC (10,000 shares) and<br \/>\nMorgan Keegan &amp; Company, Inc. (3,500 shares) (the foregoing warrants being<br \/>\ncollectively called the &#8220;Warrants&#8221;) and shares issuable upon exercise of the<br \/>\nWarrants being collectively called the &#8220;Warrant Shares&#8221;). Except as set forth in<br \/>\nSchedule 2.2(a), there are no other Common Shares to be issued (the &#8220;Contingent<br \/>\nReserved Common Shares&#8221;).<\/p>\n<p>                        (b) 3,000,000 shares of Preferred Stock with a par value<br \/>\nof $0.001 per share (the &#8220;Preferred Stock&#8221;), of which 976,220 shares have been<br \/>\ndesignated as Series A Convertible Preferred Stock (the &#8220;Series A Preferred<br \/>\nStock&#8221;), all of which are issued and outstanding, 320,000 shares have been<br \/>\ndesignated as Series B Preferred Stock (the &#8220;Series B Preferred Stock&#8221;), 294,620<br \/>\nof which are issued and outstanding, and 443,400 shares have been designated as<br \/>\nSeries C Preferred Stock (the &#8220;Series C Preferred Stock&#8221;), all of which may be<br \/>\nissued and outstanding upon the Closing.<\/p>\n<p>                        (c) Except for (A) the conversion privileges of the<br \/>\nSeries A Preferred Stock, (B) the conversion privileges of the Series B<br \/>\nPreferred Stock, (C) the conversion privileges of the Series C Preferred Stock,<br \/>\n(D) currently authorized options to purchase 110,750 shares of Common Stock<br \/>\ngranted to employees pursuant to the Stock Plan, (E) the Warrants and the (F)<br \/>\nContingent Reserved Common Shares (collectively, the &#8220;Common Stock<br \/>\nEquivalents&#8221;): (i) no subscription right, warrant, option, convertible security<br \/>\nor other right or interest (contingent or otherwise) to purchase or acquire any<br \/>\nshares of capital stock, of the Company is authorized, issued or outstanding;<br \/>\n(ii) the Company does not have any obligation (contingent or otherwise) (a) to<br \/>\nissue any subscription right, warrant, option, convertible security or other<br \/>\nsuch right or interest or (b) to issue or distribute to holders of any shares of<br \/>\nits capital stock any evidences of indebtedness or assets of the Company; and<br \/>\n(iii) the Company does not have any obligation (contingent or otherwise) to<br \/>\npurchase, redeem or otherwise acquire any shares of its capital stock or any<br \/>\ninterest therein or to pay any dividend or make any other distribution in<br \/>\nrespect thereof.<\/p>\n<p>                        (d) Attached hereto as Schedule 2.2(d) is a true and<br \/>\ncomplete list of the stockholders of the Company and all holders of any options<br \/>\nor warrants of the Company, showing the number of shares of capital stock,<br \/>\noptions or warrants of the Company held by each such person as of the date<br \/>\nhereof. Except as provided in Schedule 2.2(a) and Schedule 2.2(d), there are no<br \/>\nother holders of any subscription right, option, warrant, convertible security<br \/>\nor other right or interest that is convertible into or exercisable for shares of<br \/>\ncapital stock of the Company, and there are no statutory or, to the Company&#8217;s<br \/>\nknowledge, contractual stockholders&#8217; preemptive rights, rights of first refusal<br \/>\nor any similar rights relating to the acquisition of the capital stock of the<br \/>\nCompany.<\/p>\n<p>                2.3 Subsidiaries. Except as specified in Schedule 2.3, the<br \/>\nCompany does not have any subsidiaries or own or control, directly or<br \/>\nindirectly, any interest in any other corporation, partnership, limited<br \/>\nliability company, joint venture, association, trust, estate, limited liability<br \/>\npartnership, joint stock company, unincorporated organization or government or<\/p>\n<p>                                       3<br \/>\n   6<\/p>\n<p>any agency or political subdivision thereof, or other entity or organization<br \/>\n(each of the foregoing, together with any individual, being sometimes referred<br \/>\nto herein as a &#8220;Person&#8221;). Schedule 2.3 sets forth, as of the Initial Closing and<br \/>\ngiving effect to the transactions contemplated hereby, a complete and current<br \/>\nlist of the outstanding equity interests and the stockholders of the Company&#8217;s<br \/>\nsubsidiaries.<\/p>\n<p>                2.4 Authorization. All corporate action on the part of the<br \/>\nCompany, its directors, officers and stockholders necessary for the<br \/>\nauthorization, execution and delivery of this Agreement and the Registration<br \/>\nRights Agreement in the form attached hereto as Exhibit B, the performance of<br \/>\nall obligations of the Company hereunder and thereunder and the authorization,<br \/>\nissuance and delivery of shares of the Series C Preferred Stock pursuant to the<br \/>\nterms of this Agreement and the Common Stock issuable upon conversion of the<br \/>\nSeries C Preferred Stock has been taken or will be taken prior to the Closing,<br \/>\nand the Transaction Agreements, when executed and delivered by the Company,<br \/>\nshall constitute valid and legally binding obligations of the Company,<br \/>\nenforceable against the Company in accordance with their terms except: (i) as<br \/>\nlimited by applicable bankruptcy, insolvency, reorganization, moratorium,<br \/>\nfraudulent conveyance, and other laws of general application affecting<br \/>\nenforcement of creditors&#8217; rights generally; (ii) as limited by laws or equitable<br \/>\nprinciples relating to the availability of specific performance, injunctive<br \/>\nrelief, or other equitable remedies; or (iii) to the extent the indemnification<br \/>\nprovisions contained in the Registration Rights Agreement may be limited by<br \/>\napplicable federal or state securities laws.<\/p>\n<p>                2.5 Compliance with Securities Laws; Valid Issuance of<br \/>\nSecurities. The Series C Preferred Stock being issued to the Purchasers<br \/>\nhereunder, when issued, sold and delivered in accordance with the terms hereof<br \/>\nfor the consideration expressed herein, will be duly and validly issued,<br \/>\nfully-paid and nonassessable and free of restrictions on transfer other than<br \/>\nrestrictions on transfer under this Agreement and applicable federal and state<br \/>\nsecurities laws. Shares of the Common Stock issuable upon conversion of the<br \/>\nSeries C Preferred Stock purchased hereunder have been duly and validly reserved<br \/>\nfor issuance, and upon issuance in accordance with the terms of the Restated<br \/>\nCertificate, shall be duly and validly issued, fully-paid and nonassessable and<br \/>\nfree of restrictions on transfer other than restrictions on transfer under this<br \/>\nAgreement, the Registration Rights Agreement and applicable federal and state<br \/>\nsecurities laws.<\/p>\n<p>                2.6 Governmental Consents. No consent, approval, order or<br \/>\nauthorization of, or registration, qualification, designation, declaration or<br \/>\nfiling with, any federal, foreign, state or local governmental authority on the<br \/>\npart of the Company is required in connection with the consummation of the<br \/>\ntransactions contemplated by the Transaction Agreements, except for filings<br \/>\npursuant to applicable state securities laws and Regulation D of the Securities<br \/>\nAct of 1933, as amended (the &#8220;Securities Act&#8221;).<\/p>\n<p>                2.7 Litigation. Except as set forth on Schedule 2.7, there is no<br \/>\naction, suit, proceeding or investigation pending or, to the best of the<br \/>\nCompany&#8217;s knowledge, currently overtly threatened against the Company or any of<br \/>\nits subsidiaries, nor is the Company aware that there is any basis for the<br \/>\nforegoing. The foregoing includes, without limitations, actions, suits,<br \/>\nproceedings or investigations pending or threatened involving the prior<br \/>\nemployment of any of the Company&#8217;s employees, their use in connection with the<br \/>\nCompany&#8217;s business of any information or techniques allegedly proprietary to any<br \/>\nof their former employers, or their<\/p>\n<p>                                       4<br \/>\n   7<\/p>\n<p>obligations under any agreements with prior employers. The Company is not a<br \/>\nparty or expressly subject to the provisions of any order, writ, injunction,<br \/>\njudgment or decree of any court, administrative agency, government agency or<br \/>\ninstrumentality. There is no action, suit or proceeding by the Company currently<br \/>\npending or which the Company intends to initiate.<\/p>\n<p>                2.8 Intellectual Property.<\/p>\n<p>                        (a) To the best knowledge of the Company, the Company<br \/>\nhas sufficient title and ownership of, or rights by license or other agreement<br \/>\nto, all patents, patent applications, trademarks, service marks, trade names,<br \/>\ndomain names, URLs, copyrights, trade secrets, software, source codes, object<br \/>\ncodes and other intellectual property rights used by the Company in its business<br \/>\nor necessary to conduct its business as currently conducted (&#8220;Intellectual<br \/>\nProperty&#8221;). The Company has not received any written communications alleging<br \/>\nthat the Company has violated or, by conducting its business as now conducted,<br \/>\nwould violate any of the rights in the Intellectual Property of any other<br \/>\nPerson. The Company is not aware that any of its employees are obligated under<br \/>\nany contract (including licenses, covenants or commitments of any nature) or<br \/>\nother agreement, or subject to any judgment, decree or order of any court or<br \/>\nadministrative agency, that would interfere with the use of his or her best<br \/>\nefforts to promote the interests of the Company or that would conflict with the<br \/>\nCompany&#8217;s business as currently conducted. The Company has not licensed any of<br \/>\nthe Intellectual Property to any other Person, nor does any other Person have an<br \/>\noption or any other right to acquire any of the Intellectual Property other than<br \/>\nin the ordinary course of business (except for the Intellectual Property that is<br \/>\nin the public domain). Schedule 2.8(a) sets forth a list of the Company&#8217;s<br \/>\nmaterial intellectual property.<\/p>\n<p>                        (b) All licenses or agreements listed in Schedule 2.8(b)<br \/>\n(the &#8220;Certain IP Agreements&#8221;) are in full force and effect and to the best<br \/>\nknowledge of the Company there is no default by any party thereto. True and<br \/>\ncomplete copies of all Certain IP Agreements, and any amendments thereto, have<br \/>\nbeen made available to the Purchasers, and to the best knowledge of the Company,<br \/>\nthe licensors under the Certain IP Agreements to which the Company is granted<br \/>\nrights, to the best of the Company&#8217;s knowledge, have all requisite power and<br \/>\nauthority to grant the rights purported to be conferred thereby. None of the<br \/>\nproducts manufactured and sold, nor any process or know-how used, by the Company<br \/>\nunder the Certain IP Agreements infringes or is alleged to infringe any patent,<br \/>\ntrademark, service mark, trade name, copyright or other proprietary right or is<br \/>\na derivative work based on the work of any other person.<\/p>\n<p>                2.9 Compliance with Other Instruments. The Company is not in<br \/>\nviolation or in default of any provisions of (i) its Certificate of<br \/>\nIncorporation, as amended, or Bylaws or (ii) any order, writ, injunction,<br \/>\njudgment, instrument, decree or contract to which it is a party or by which it<br \/>\nis bound or (iii) to the Company&#8217;s knowledge, any provision of a federal or<br \/>\nstate statute, rule or regulation applicable to the Company, which violations or<br \/>\ndefaults would in the case of the items described in clauses (ii) and (iii),<br \/>\neither individually or in the aggregate, have a Material Adverse Effect. The<br \/>\nexecution, delivery and performance of the Transaction Agreements and the<br \/>\nconsummation of the transactions contemplated hereby or thereby do not and will<br \/>\nnot, with or without the passage of time and\/or the giving of notice: (a) result<br \/>\nin any such violation or conflict with or constitute a default under any such<br \/>\nprovision, order, writ, injunction, judgment, instrument, decree or contract or<br \/>\nany such statute, rule or regulation; (b)<\/p>\n<p>                                       5<br \/>\n   8<\/p>\n<p>result in the creation of any lien, security interest, charge or encumbrance<br \/>\nupon the capital stock or any assets of the Company; or (c) give any third party<br \/>\nthe right to modify, terminate or accelerate any obligation under any such<br \/>\nprovision, order, writ, injunction, judgment, instrument, decree or contract.<\/p>\n<p>                2.10 Agreements. Schedule 2.10 sets forth a list of all material<br \/>\nagreements, contracts, understandings or commitments, written or oral<br \/>\n(collectively, &#8220;Material Agreements&#8221;), to which the Company is a party or by<br \/>\nwhich it is bound. As used herein, Material Agreements shall mean:<\/p>\n<p>                        (a) Agreements, contracts, understandings or commitments<br \/>\nbetween the Company and any of its subsidiaries, officers, directors or<br \/>\naffiliates or any of such officers&#8217;, directors&#8217; or affiliates&#8217; immediate family<br \/>\nmembers.<\/p>\n<p>                        (b) Agreements, contracts, understandings or commitments<br \/>\nto which the Company or any of its affiliates is a party or by which it is bound<br \/>\nthat involve obligations (contingent or otherwise) of, or payments to, the<br \/>\nCompany in excess of, $250,000.<\/p>\n<p>                        All of such agreements, contracts understanding or<br \/>\ncommitments are valid, binding and in full force and effect with respect to the<br \/>\nCompany or any of its subsidiaries, except as set forth on Schedule 2.10(b), and<br \/>\nthere has been no material default by the Company under any of the foregoing nor<br \/>\nto the Company&#8217;s knowledge has there been any material default by any other<br \/>\nparty thereto.<\/p>\n<p>                2.11 Absence of Undisclosed Liabilities. Except as set forth on<br \/>\nSchedule 2.11, since the Statement Date (as hereafter defined), the Company and<br \/>\nany of its subsidiaries has not: (i) declared or paid any dividends, or<br \/>\nauthorized or made any distribution upon or with respect to any class or series<br \/>\nof the Company&#8217;s capital stock; (ii) incurred any indebtedness on behalf of the<br \/>\nCompany for money borrowed or incurred any other liabilities in excess of<br \/>\n$50,000 individually, or in excess of $100,000 in the aggregate to any one<br \/>\ncreditor; (iii) made any loans or advances to any Person in the name of or with<br \/>\nrespect to the Company, other than ordinary advances for expenses incurred in<br \/>\nthe ordinary course of business consistent with past practices; or (iv) sold,<br \/>\nexchanged or otherwise disposed of any of the Company&#8217;s assets or rights, other<br \/>\nthan in the ordinary course of business consistent with past practices.<\/p>\n<p>                2.12 Disclosure. None of the representations or warranties of<br \/>\nthe Company contained in this Agreement, the schedules and exhibits attached<br \/>\nhereto, nor any certificate furnished or to be furnished to the Purchasers at<br \/>\nClosing (when read together) contains any untrue statement of a material fact or<br \/>\nomits to state a material fact necessary to make the statements contained herein<br \/>\nor therein not misleading in light of the circumstances under which they were<br \/>\nmade.<\/p>\n<p>                2.13 No Conflict of Interest. The Company is not indebted,<br \/>\ndirectly or indirectly, to any of its subsidiaries or officers or directors of<br \/>\nthe Company or its subsidiaries or, to the knowledge of the Company or its<br \/>\nsubsidiaries, such officers&#8217; or directors&#8217; respective spouses or immediate<br \/>\nfamily members, for any amount whatsoever. Except as set forth on Schedule 2.13<br \/>\nattached hereto, none of the Company&#8217;s subsidiaries or officers or directors of<br \/>\nthe<\/p>\n<p>                                       6<br \/>\n   9<\/p>\n<p>Company or its subsidiaries or, to the knowledge of the Company or its<br \/>\nsubsidiaries, no member of such officers&#8217; or directors&#8217; immediate families (x)<br \/>\nare, directly or indirectly, indebted to the Company or, (y) have any direct or<br \/>\nindirect ownership interest in any Person (A) with which the Company is<br \/>\naffiliated or (B) with which the Company has a material business relationship,<br \/>\nor (C) which competes with the Company; except that for purposes of this clause<br \/>\n(y), officers, directors and\/or stockholders of the Company may own stock in<br \/>\n(but not exceeding five percent (5%) of the outstanding capital stock of) any<br \/>\npublicly traded companies that may compete with the Company. To the best of the<br \/>\nCompany&#8217;s knowledge, none of the Company&#8217;s officers or directors or any members<br \/>\nof their immediate families are, directly or indirectly, interested in any<br \/>\nmaterial contract of the Company. The Company is not a guarantor or indemnitor<br \/>\nof any indebtedness of any other Person.<\/p>\n<p>                2.14 Registration Rights and Voting Rights. Except as<br \/>\ncontemplated in the Registration Rights Agreement, there are no agreements,<br \/>\nwritten or oral, between the Company and any Person relating to the registration<br \/>\nof its capital stock under federal or state securities laws, including piggyback<br \/>\nregistration rights. To the knowledge of the Company, no stockholders of the<br \/>\nCompany have entered into any agreements with respect to the voting of shares of<br \/>\nthe capital stock of the Company.<\/p>\n<p>                2.15 Private Placement. Subject to and in reliance in part on<br \/>\nthe truth and accuracy of the Purchasers&#8217; representations set forth in this<br \/>\nAgreement, the offer, sale and issuance of the Series C Preferred Stock as<br \/>\ncontemplated by this Agreement is exempt from the registration requirements of<br \/>\nthe Securities Act and any applicable state securities laws, and neither the<br \/>\nCompany nor any authorized agent acting on its behalf will take any action<br \/>\nhereafter that would cause the loss of such exemption.<\/p>\n<p>                2.16 Title to Property and Assets. The Company owns its property<br \/>\nand assets free and clear of all mortgages, liens, loans and encumbrances,<br \/>\nexcept such encumbrances and liens which arise in the ordinary course of<br \/>\nbusiness and which do not materially impair the Company&#8217;s ownership or use of<br \/>\nsuch property or assets. With respect to the property and assets it leases, the<br \/>\nCompany is in compliance with such leases and holds a valid leasehold interest<br \/>\nfree of any liens, claims or encumbrances.<\/p>\n<p>                2.17 Employee Benefit Plans. Except as specified in Schedule<br \/>\n2.17, the Company does not have any employee benefit plan and is not a party to<br \/>\nany multiemployer plan as such terms are defined in the Employee Retirement<br \/>\nIncome Security Act of 1974, as amended.<\/p>\n<p>                2.18 Tax Returns and Audits. The Company and, to the Company&#8217;s<br \/>\nknowledge, any of its subsidiaries has accurately prepared and timely filed all<br \/>\nmaterial federal, state, foreign, local and other tax returns required by law to<br \/>\nbe filed by each of them, has paid or made provision for the payment of all<br \/>\ntaxes shown to be due and all additional assessments, and adequate provisions<br \/>\nhave been made and are reflected in the Company&#8217;s financial statements in all<br \/>\nmaterial respects to the extent required by generally accepted accounting<br \/>\nprinciples applied on a consistent basis and as in effect in the United States<br \/>\n(&#8220;GAAP&#8221;) for all current taxes and other charges to which the Company or its<br \/>\nsubsidiaries is subject and which are not currently due and payable. There are<br \/>\nno additional assessments or adjustments pending or, to the knowledge of the<br \/>\nCompany, threatened against the Company or its subsidiaries for any period, and<br \/>\nto the<\/p>\n<p>                                       7<br \/>\n   10<\/p>\n<p>Company&#8217;s knowledge, there is no basis for any such assessment or adjustment<br \/>\nthat would be material.<\/p>\n<p>                2.19 Labor Agreements and Actions. The Company is not bound by<br \/>\nor subject to (and none of its assets or properties is bound by or subject to)<br \/>\nany written or oral contract, commitment, agreement or arrangement with any<br \/>\nlabor union, and no labor union has requested or, to the knowledge of the<br \/>\nCompany, has sought to represent any of the employees, representatives or agents<br \/>\nof the Company. There is no strike or other labor dispute involving the Company<br \/>\npending or, to the knowledge of the Company, threatened, which could have a<br \/>\nMaterial Adverse Effect, nor is the Company aware of any labor organization<br \/>\nactivity involving the employees, representatives or agents of the Company. The<br \/>\nCompany has complied in all material respects with all applicable federal and<br \/>\nstate equal employment opportunity laws and regulations and with all other laws<br \/>\nand regulations related to employment and labor issues. The Company has not<br \/>\nreceived any notice of any plan of any key employee to terminate his or her<br \/>\nemployment with the Company.<\/p>\n<p>                2.20 Proprietary Information and Inventions Agreements. Each<br \/>\ncurrent employee, consultant and officer of the Company has executed an<br \/>\nagreement with the Company regarding confidentiality and proprietary information<br \/>\nsubstantially in the form attached as Exhibit C. The Company, after reasonable<br \/>\ninvestigation, is not aware that any of its current employees or consultants is<br \/>\nin violation thereof, and the Company will use commercially reasonable efforts<br \/>\nto prevent any such violation. To the Company&#8217;s knowledge, no consultants to or<br \/>\nvendors of the Company have had any access to confidential information of the<br \/>\nCompany who are not bound by non-disclosure agreements.<\/p>\n<p>                2.21 Permits. The Company has all franchises, permits, licenses<br \/>\nand any other governmental authorizations necessary for the conduct of its<br \/>\nbusiness as now being conducted, the lack of which could have a Material Adverse<br \/>\nEffect. The Company is not in default in any material respect under any of such<br \/>\nfranchises, permits, licenses or other authorizations.<\/p>\n<p>                2.22 Corporate Documents. The Restated Certificate and Bylaws of<br \/>\nthe Company are in the form provided to each of the Purchasers. As of the<br \/>\nClosing, the Bylaws of the Company shall be in the form of the Bylaws attached<br \/>\nhereto as Exhibit D. The copy of the minute book of the Company provided to the<br \/>\nPurchasers contains minutes of all meetings of directors and stockholders of the<br \/>\nCompany and all actions by written consent without a meeting by the directors<br \/>\nand stockholders of the Company since the date of the incorporation of the<br \/>\nCompany, and reflects all actions by the directors (and any committee of<br \/>\ndirectors) and stockholders of the Company with respect to all transactions<br \/>\nreferred to in such minutes accurately in all material respects.<\/p>\n<p>                2.23 Real Property Holding Corporation. Neither the Company nor<br \/>\nany of its subsidiaries is a United States real property holding corporation<br \/>\nwithin the meaning of Internal Revenue Code Section 897(c)(2) and Section<br \/>\n1.897-2(c) of the Treasury Regulations promulgated thereunder.<\/p>\n<p>                2.24 Financial Statements. The Company has made available to the<br \/>\nPurchasers (i) an audited balance sheet as of June 30, 2000; (ii) an audited<br \/>\nincome statement as of June 30,<\/p>\n<p>                                       8<br \/>\n   11<\/p>\n<p>2000; (iii) an unaudited balance sheet as of March 31, 2001 (the &#8220;Statement<br \/>\nDate&#8221;); and (iv) an unaudited income statement for the three months ended March<br \/>\n31, 2001, copies of which are included as Schedule 2.24 (the &#8220;Financial<br \/>\nStatements&#8221;). The Financial Statements have been prepared from the books and<br \/>\nrecords of the Company and are complete and correct in all material respects and<br \/>\nfairly present the consolidated financial condition and operating results of the<br \/>\nCompany as of the Statement Date and for the period presented. Except as set<br \/>\nforth in the Financial Statements, the Company does not have any material<br \/>\nliabilities, contingent or otherwise, other than (i) liabilities paid or<br \/>\nincurred in the ordinary course of business subsequent to the Statement Date,<br \/>\nand (ii) obligations under contracts and commitments incurred in the ordinary<br \/>\ncourse of business.<\/p>\n<p>                2.25 Changes. Since the Statement Date and except as<br \/>\ncontemplated by this Agreement and the exhibits and schedules hereto, there has<br \/>\nnot been:<\/p>\n<p>                        (a) any change in the assets, liabilities, financial<br \/>\ncondition or operating results of the Company from that reflected in the<br \/>\nFinancial Statements, except for changes in the ordinary course of business or<br \/>\nthat have not resulted in a Material Adverse Effect;<\/p>\n<p>                        (b) any damage, destruction or loss to property, whether<br \/>\nor not covered by insurance, resulting in a Material Adverse Effect;<\/p>\n<p>                        (c) any satisfaction or discharge of any lien, claim or<br \/>\nencumbrance or payment of any obligation by the Company except in the ordinary<br \/>\ncourse of business or that has not resulted in a Material Adverse Effect;<\/p>\n<p>                        (d) any material change to a material contract or<br \/>\nagreement by which the Company or any of its assets are bound or subject, except<br \/>\nas specified in Schedule 2.25(d);<\/p>\n<p>                        (e) any material change in any compensation arrangement<br \/>\nor agreement with any employee, representative, agent, officer, director or<br \/>\nstockholder of the Company, except as specified in Schedule 2.25(e);<\/p>\n<p>                        (f) any resignation or termination of employment of any<br \/>\nofficer, director or key employee of the Company and, to the best of the<br \/>\nCompany&#8217;s knowledge, the Company does not know of any impending resignation or<br \/>\ntermination of employment of any such officer, director or key employee;<\/p>\n<p>                        (g) receipt of notice that there has been a loss of, or<br \/>\nmaterial order cancellation by, any major advertiser or major customer of the<br \/>\nCompany other than in the ordinary course of business;<\/p>\n<p>                        (h) any mortgage, pledge, transfer of a security<br \/>\ninterest in, lien or encumbrance, created by the Company, with respect to any of<br \/>\nits capital stock, properties or assets, except liens for taxes not yet due or<br \/>\npayable;<\/p>\n<p>                        (i) any loans or guarantees made by the Company to or<br \/>\nfor the benefit of its employees, representatives, agents, officers or<br \/>\ndirectors, or any members of their<\/p>\n<p>                                       9<br \/>\n   12<\/p>\n<p>immediate families, other than ordinary advances for expenses incurred in the<br \/>\nordinary course of business, except as specified in Schedule 2.25(i);<\/p>\n<p>                        (j) any declaration, setting aside or payment or other<br \/>\ndistribution in respect to any of the Company&#8217;s capital stock, or any direct or<br \/>\nindirect redemption, purchase, or other acquisition of any of such capital stock<br \/>\nby the Company other than the purchase of capital stock of officers, directors<br \/>\nor employees who have terminated their relationship with the Company; or<\/p>\n<p>                        (k) any arrangement or commitment by the Company to do<br \/>\nanything described in this Section 2.25.<\/p>\n<p>                2.26 Environmental and Safety Laws. The Company is not in<br \/>\nviolation of any applicable statute, law or regulation relating to the<br \/>\nenvironment or occupational health and safety where such violation is likely to<br \/>\nresult in a Material Adverse Effect, and no material expenditures are presently<br \/>\nrequired by the Company in order to comply with any such applicable statute, law<br \/>\nor regulation.<\/p>\n<p>                2.27 FCPA. The Company has complied in all material respects<br \/>\nwith the United States Foreign Corrupt Practices Act of 1977, as amended (the<br \/>\n&#8220;FCPA&#8221;), in obtaining any consents, licenses, approvals, authorizations, rights,<br \/>\nand privileges in connection with the conduct of its business, and has otherwise<br \/>\nconducted its business in all material respects in compliance with the FCPA. The<br \/>\nCompany&#8217;s internal management and accounting practices and controls are adequate<br \/>\nto ensure compliance in all material respects with the FCPA.<\/p>\n<p>                2.28 Projections. Any projections provided to the Purchasers by<br \/>\nthe Company were made in good faith and were based upon reasonable assumptions<br \/>\nwhen made.<\/p>\n<p>        3. Representations and Warranties of Purchasers. Each Purchaser hereby,<br \/>\nseverally and not jointly, represents and warrants to the Company, with respect<br \/>\nto itself only, that:<\/p>\n<p>                3.1 Accredited Investor; Authorization. Such Purchaser is an<br \/>\n&#8220;accredited investor&#8221; within the meaning of Rule 501 promulgated under the<br \/>\nSecurities Act and has the corporate, partnership or individual, as the case may<br \/>\nbe, power and authority to enter into and perform this Agreement and the other<br \/>\nTransaction Agreements to which it is a party and to consummate the transactions<br \/>\ncontemplated hereby and thereby. This Agreement has been duly authorized,<br \/>\nexecuted and delivered by such Purchaser and constitutes the legal, valid and<br \/>\nbinding obligation of such Purchaser, enforceable in accordance with its terms<br \/>\nexcept: (i) as such enforceability may be limited by applicable bankruptcy,<br \/>\ninsolvency, reorganization, moratorium, fraudulent conveyance, and other laws of<br \/>\ngeneral application affecting enforcement of creditors&#8217; rights generally; or<br \/>\n(ii) as such enforceability may be limited by laws or equitable principles<br \/>\nrelating to the availability of specific performance, injunctive relief, or<br \/>\nother equitable remedies.<\/p>\n<p>                3.2 No Conflict With Other Agreements. The execution, delivery<br \/>\nand performance of the Transaction Agreements to which such Purchaser is a party<br \/>\nand the consummation of the transactions contemplated hereby or thereby will<br \/>\nnot, with or without the passage of time and\/or the giving of notice, result in<br \/>\na violation or default of any provisions of such Purchaser&#8217;s charter, bylaws,<br \/>\npartnership agreement, certificate of limited partnership,<\/p>\n<p>                                       10<br \/>\n   13<\/p>\n<p>limited liability company agreement, certificate of formation or other<br \/>\norganizational document or of any order, writ, injunction, judgment, instrument,<br \/>\ndecree or contract to which it is a party or by which it is bound or, to its<br \/>\nknowledge, of any material provision of a federal or state statute, rule or<br \/>\nregulation applicable to such Purchaser.<\/p>\n<p>                3.3 Investment Experience. Such Purchaser is a regular purchaser<br \/>\nof securities and acknowledges that it is able to fend for itself, can bear the<br \/>\neconomic risk of its investment, and has such knowledge and experience in<br \/>\nfinancial or business matters that it is capable of evaluating the merits and<br \/>\nrisks of the investment in the Company.<\/p>\n<p>                3.4 Distribution. The Series C Preferred Stock (and the Common<br \/>\nStock issuable upon conversion thereof) is being acquired for such Purchaser&#8217;s<br \/>\nown account, and not as nominee or agent, for the present intention of holding<br \/>\nsuch securities for purposes of investment and not with a view to or for resale<br \/>\nin connection with any distribution thereof. Such Purchaser further represents,<br \/>\nseverally and not jointly, that it understand and agrees that, until registered<br \/>\nunder the Securities Act or transferred pursuant to the provisions of Rule 144<br \/>\nas promulgated by the Securities and Exchange Commission, all certificates<br \/>\nevidencing any of the Series C Preferred Stock (and the Common Stock issuable<br \/>\nupon conversion thereof), whether upon initial issuance or upon any transfer<br \/>\nthereof, shall bear legends, prominently stamped or printed thereon, reading<br \/>\nsubstantially as follows:<\/p>\n<p>        (a) Federal Legend. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE<br \/>\n        SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;ACT&#8221;), OR UNDER ANY STATE<br \/>\n        SECURITIES LAWS. THESE SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE,<br \/>\n        PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN<br \/>\n        EFFECT WITH RESPECT TO THESE SECURITIES UNDER THE ACT OR APPLICABLE<br \/>\n        STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY<br \/>\n        TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED OR UNLESS SOLD<br \/>\n        PURSUANT TO RULE 144 OF THE ACT.<\/p>\n<p>        (b) any legend required by applicable state securities laws.<\/p>\n<p>        The Company need not register a transfer of legended Series C Preferred<br \/>\nStock, and may also instruct its transfer agent not to register the transfer of<br \/>\nthe Series C Preferred Stock, unless the conditions specified in the foregoing<br \/>\nlegends are satisfied.<\/p>\n<p>                3.5 Disclosure of Information. Such Purchaser has received all<br \/>\nthe information it considers necessary or appropriate for deciding whether to<br \/>\npurchase the Series C Preferred Stock. Such Purchaser further represents that it<br \/>\nhas had an opportunity to ask questions and receive answers from the Company<br \/>\nregarding the terms and conditions of the offering of the Series C Preferred<br \/>\nStock and the business, properties, prospects and financial condition of the<br \/>\nCompany. The foregoing, however, does not limit or modify the representations<br \/>\nand warranties of the Company in Section 2 of this Agreement or the right of the<br \/>\nPurchasers to rely thereon.<\/p>\n<p>                                       11<br \/>\n   14<\/p>\n<p>                3.6 Restricted Securities. Such Purchaser understands that the<br \/>\nshares of Series C Preferred Stock it is purchasing are characterized as<br \/>\n&#8220;restricted securities&#8221; under the federal securities laws inasmuch as they are<br \/>\nbeing acquired from the Company in a transaction not involving a public offering<br \/>\nand that under such laws and applicable regulations such securities may be<br \/>\nresold without registration under the Act only in certain limited circumstances.<br \/>\nIn this connection, such Purchaser represents that it is familiar with SEC Rule<br \/>\n144, as presently in effect, and understands the resale limitations imposed<br \/>\nthereby and by the Securities Act of 1933, as amended.<\/p>\n<p>                3.7 Further Representations by Foreign Purchasers. If a<br \/>\nPurchaser is not a United States person, such Purchaser hereby represents that<br \/>\nhe or she has satisfied himself or herself as to the full observance of the laws<br \/>\nof his or her jurisdiction in connection with any invitation to subscribe for<br \/>\nshares of Series C Preferred Stock or any use of this Agreement, including (i)<br \/>\nthe legal requirements within his jurisdiction for the purchase of shares of<br \/>\nSeries C Preferred Stock, (ii) any foreign exchange restrictions applicable to<br \/>\nsuch purchase, (iii) any governmental or other consents that may need to be<br \/>\nobtained, and (iv) the income tax and other tax consequences, if any, that may<br \/>\nbe relevant to the purchase, holding, redemption, sale, or transfer of shares of<br \/>\nSeries C Preferred Stock. Such Purchaser&#8217;s subscription and payment for, and his<br \/>\nor her continued beneficial ownership of shares of Series C Preferred Stock,<br \/>\nwill not violate any applicable securities or other laws of his or her<br \/>\njurisdiction.<\/p>\n<p>                3.8 Not Formed for Investment. Such Purchaser was not formed for<br \/>\nthe purpose of making an investment in the Company.<\/p>\n<p>        4. Conditions of Purchasers&#8217; Obligations at the Closing. The obligations<br \/>\nof each Purchaser to the Company under this Agreement are subject to the<br \/>\nfulfillment, on or before the Closing, of each of the following conditions,<br \/>\nunless otherwise waived in writing by such Purchaser.<\/p>\n<p>                4.1 Representations and Warranties. The representations and<br \/>\nwarranties of the Company contained in Section 2 shall be true and correct in<br \/>\nall material respects on and as of the Initial Closing.<\/p>\n<p>                4.2 Performance. The Company shall have performed and complied<br \/>\nin all material respects with all covenants, agreements, obligations and<br \/>\nconditions contained in this Agreement that are required to be performed or<br \/>\ncomplied with by the Company on or before the Closing.<\/p>\n<p>                4.3 Compliance Certificate. The President of the Company shall<br \/>\ndeliver to each Purchaser at the Closing a certificate certifying that the<br \/>\nconditions specified in Sections 4.1 and 4.2 have been fulfilled.<\/p>\n<p>                4.4 Qualifications. All authorizations, approvals or permits, if<br \/>\nany, of any governmental authority or regulatory body of the United States or of<br \/>\nany state that are required in connection with the lawful issuance and sale of<br \/>\nthe Series C Preferred Stock pursuant to this Agreement shall be obtained and<br \/>\neffective as of the Closing.<\/p>\n<p>                                       12<br \/>\n   15<\/p>\n<p>                4.5 Opinion of Company Counsel. The Purchasers shall have<br \/>\nreceived from Doty Sundheim &amp; Gilmore, counsel for the Company, an opinion,<br \/>\ndated as of the Closing, in substantially the form of Exhibit E attached hereto.<\/p>\n<p>                4.6 Supporting Documents. The Purchasers shall have received the<br \/>\nfollowing:<\/p>\n<p>                        (a) A copy of resolutions of the Board of Directors of<br \/>\nthe Company authorizing and approving the Transaction Agreements and copies of<br \/>\nresolutions of the Board of Directors and stockholders of the Company<br \/>\nauthorizing and approving the adoption of the Restated Certificate that is<br \/>\ncontemplated by this Agreement, all such resolutions to be certified by the<br \/>\nSecretary of the Company;<\/p>\n<p>                        (b) A Certificate of Incumbency executed by the<br \/>\nSecretary of the Company certifying the names, titles and signatures of the<br \/>\nofficers authorized to execute the Transaction Agreements and further certifying<br \/>\nthat the Restated Certificate and Bylaws of the Company delivered to the<br \/>\nPurchasers at the time of the execution of this Agreement have been validly<br \/>\nadopted and have not been amended or modified except as required by this<br \/>\nAgreement; and<\/p>\n<p>                        (c) Such additional supporting documentation and other<br \/>\ninformation with respect to the transactions contemplated hereby as any<br \/>\nPurchaser or its legal counsel may reasonably request.<\/p>\n<p>                4.7 Board of Directors. As of the Initial Closing, the Company&#8217;s<br \/>\nBoard of Directors shall consist of no more than 8 members. Effective as of the<br \/>\ntime of the Initial Closing, by appropriate action of the Board of Directors<br \/>\nand\/or the Stockholders of the Company, one person designated by PAR Capital<br \/>\nManagement, Inc. (&#8220;PAR&#8221; and such designee the &#8220;PAR Designee&#8221;) shall be elected<br \/>\nor appointed to the Company&#8217;s Board of Directors, if not already on the Board of<br \/>\nDirectors. All other members of the Company&#8217;s Board of Directors (not to exceed<br \/>\n7 in number) shall remain as members of the Board of Directors, subject to the<br \/>\nprovisions of the Company&#8217;s Restated Certificate and Bylaws as from time to time<br \/>\nin effect.<\/p>\n<p>                4.8 Registration Rights Agreement. The Company, each Purchaser<br \/>\nthat is a party thereto and the other parties thereto shall have executed and<br \/>\ndelivered the Registration Rights Agreement in substantially the form attached<br \/>\nhereto as Exhibit B.<\/p>\n<p>                4.9 Restated Certificate. The Company shall have filed the<br \/>\nRestated Certificate with the Secretary of State of Delaware on or prior to the<br \/>\ndate of the Closing, which shall continue to be in full force and effect as of<br \/>\nthe date of the Closing.<\/p>\n<p>                4.10 Employment Agreements. The members of the Company&#8217;s senior<br \/>\nmanagement shall have entered into a Proprietary Information and Inventions<br \/>\nAgreement in the form attached hereto as Exhibit C.<\/p>\n<p>                4.11 Co-Sale and Right of First Refusal Agreement. The Company,<br \/>\nRaymond C. Musci, Anthony R. Williams and each Purchaser shall have executed and<br \/>\ndelivered the Co-Sale and Right of First Refusal Agreement substantially in the<br \/>\nform attached hereto as Exhibit F.<\/p>\n<p>                                       13<br \/>\n   16<\/p>\n<p>        5. Conditions of the Company&#8217;s Obligations at the Closing. The<br \/>\nobligations of the Company to each Purchaser under this Agreement are subject to<br \/>\nthe fulfillment, on or before the Closing, of each of the following conditions,<br \/>\nunless otherwise waived by the Company in writing; provided, however, that the<br \/>\nnon-fulfillment of a condition by a Purchaser will not relieve the Company of<br \/>\nits obligation to each other fulfilling Purchaser.<\/p>\n<p>                5.1 Representations and Warranties. The representations and<br \/>\nwarranties of such Purchaser contained in Section 3 shall be true and correct on<br \/>\nand as of the date of the Closing with the same effect as though such<br \/>\nrepresentations and warranties had been made on and as of the date of Closing.<\/p>\n<p>                5.2 Performance. All covenants, agreements and conditions<br \/>\ncontained in this Agreement to be performed by such Purchaser on or prior to the<br \/>\nClosing shall have been performed or complied with.<\/p>\n<p>                5.3 Registration Rights Agreement. Such Purchaser shall have<br \/>\nexecuted and delivered the Registration Rights Agreement in substantially the<br \/>\nform attached hereto as Exhibit B.<\/p>\n<p>                5.4 Payment of Purchase Price. Each Purchaser shall have<br \/>\ndelivered the purchase price specified in Section 1.1 of this Agreement.<\/p>\n<p>                5.5 Qualifications. All authorizations, approvals, or permits,<br \/>\nif any, of any governmental authority or regulatory body of the United States or<br \/>\nof any state that are required in connection with the lawful issuance and sale<br \/>\nof the Series C Preferred Stock pursuant to this Agreement shall be obtained and<br \/>\neffective as of the Closing.<\/p>\n<p>        6. Post-Closing Covenants. The Company and Purchasers agree as follows<br \/>\nwith respect to the period following the Closing.<\/p>\n<p>                6.1 Financial Reporting. The Company shall provide Purchasers<br \/>\nwith the following periodic reports: (a) as soon as available, but in any event<br \/>\nwithin forty five (45) days after the end of each quarter accounting period in<br \/>\neach fiscal year, unaudited statements of income, operations and cash flows of<br \/>\nthe Company for such quarterly period and unaudited balance sheets of the<br \/>\nCompany as of the end of such quarter period and all such statements shall be<br \/>\nprepared in accordance with GAAP (provided, however, that such statements need<br \/>\nnot comply with the footnote disclosure requirements of GAAP); and (b) as soon<br \/>\nas available, but in any event within ninety (90) days after the end of each<br \/>\nfiscal year, audited statements of income, operations, retained earnings and<br \/>\ncash flows of the Company for such fiscal year and audited balance sheets of the<br \/>\nCompany as of the end of such fiscal year, all prepared in accordance with GAAP,<br \/>\nall in reasonable detail and duly certified by the accountants, who shall have<br \/>\ngiven the Company an opinion, unqualified as to the scope of the audit,<br \/>\nregarding such statements.<\/p>\n<p>                6.2 Participation Rights. Purchasers shall have the right, but<br \/>\nnot the obligation, to participate pro rata (on the same terms and at the same<br \/>\nprice) in any offering and sale of stock (common or preferred) made by the<br \/>\nCompany to any person or entity after the date<\/p>\n<p>                                       14<br \/>\n   17<\/p>\n<p>of this Agreement (the &#8220;Purchaser Participation Right&#8221;); provided, however, that<br \/>\nthis Section 6.2 shall not apply in the case of the grant of options to<br \/>\nofficers, directors and employees pursuant to the terms of the Stock Plan, the<br \/>\npurchase of Common Stock upon the exercise of such options or the purchase of<br \/>\nWarrant Shares upon the exercise of the Warrants. The Purchaser Participation<br \/>\nRight shall expire and terminate upon the successful completion by the Company<br \/>\nof a Qualified Public Offering (as defined in Exhibit A) and shall not apply in<br \/>\nthe event of a Qualified Public Offering.<\/p>\n<p>                6.3 Compensation Committee. PAR Designee shall be a member of<br \/>\nthe Company&#8217;s Compensation Committee (the &#8220;Compensation Committee&#8221;). All<br \/>\ncompensation arrangements of the Company&#8217;s key employees, officers and directors<br \/>\nshall be approved by the Compensation Committee; provided, however, that so long<br \/>\nas less than a majority of the Compensation Committee consists of outside<br \/>\ndirectors such approval shall require an affirmative vote or consent of the PAR<br \/>\nDesignee. For the purpose of this Section 6.3, &#8220;outside directors&#8221; shall not<br \/>\ninclude any director employed by the Company or who holds (individually or<br \/>\nthrough an entity or entities) at least 1% of the outstanding capital stock of<br \/>\nthe Company.<\/p>\n<p>        7. Miscellaneous.<\/p>\n<p>                7.1 Survival of Warranties. The representations, warranties and<br \/>\ncovenants of the Company and the Purchasers contained in or made pursuant to<br \/>\nthis Agreement shall survive the execution and delivery of this Agreement and<br \/>\neach Closing.<\/p>\n<p>                7.2 Transfer; Successors and Assigns. The terms and conditions<br \/>\nof this Agreement shall inure to the benefit of and be binding upon the<br \/>\nrespective successors and assigns of the parties.<\/p>\n<p>                7.3 No Third Party Beneficiaries. Nothing express or implied in<br \/>\nthis Agreement is intended to confer, nor shall anything herein confer, upon any<br \/>\nother than the parties hereto and the respective successors or assigns of such<br \/>\nparties, any rights, remedies, obligations or liabilities whatsoever.<\/p>\n<p>                7.4 Governing Law. THE LAWS OF THE STATE OF CALIFORNIA SHALL<br \/>\nGOVERN THE INTERPRETATION, VALIDITY AND PERFORMANCE OF THE TERMS OF THIS<br \/>\nAGREEMENT REGARDLESS OF THE LAW THAT MIGHT BE APPLIED UNDER PRINCIPLES OF<br \/>\nCONFLICTS OF LAW.<\/p>\n<p>                7.5 Counterparts. This Agreement may be executed in one or more<br \/>\ncounterparts, each of which shall be deemed an original and all of which<br \/>\ntogether shall constitute one instrument.<\/p>\n<p>                7.6 Titles and Subtitles. The titles and subtitles used in this<br \/>\nAgreement are used for convenience only and are not to be considered in<br \/>\nconstruing or interpreting this Agreement.<\/p>\n<p>                7.7 Notices. Any notice required or permitted by this Agreement<br \/>\nshall be in writing and shall be deemed given upon delivery, when delivered<br \/>\npersonally or by overnight courier or sent by telegram or fax, or forty-eight<br \/>\n(48) hours after being deposited in the U.S.<\/p>\n<p>                                       15<br \/>\n   18<\/p>\n<p>mail, as certified or registered mail, with postage prepaid, addressed to the<br \/>\nparty to be notified at such party&#8217;s address as set forth below or on Schedule 1<br \/>\nhereto, or as subsequently modified by written notice, and:<\/p>\n<p>                (a)      if to the Company:<\/p>\n<p>                         BAM! Entertainment, Inc.<br \/>\n                         333 West Santa Clara Street<br \/>\n                         Suite 930<br \/>\n                         San Jose, California  95113<br \/>\n                         Attention:  Raymond C. Musci<br \/>\n                         Facsimile:  (408) 298-9600<\/p>\n<p>                         with a copy to:<\/p>\n<p>                         Doty Sundheim &amp; Gilmore<br \/>\n                         260 Sheridan Avenue<br \/>\n                         Suite 200<br \/>\n                         Palo Alto, California  94306<br \/>\n                         Attention:  George M. Sundheim III, Esq.<br \/>\n                         Facsimile:  (650) 327-0101<\/p>\n<p>                (b)      if to PAR:<\/p>\n<p>                         PAR Capital Management, Inc.<br \/>\n                         One Financial Center, Suite 1600<br \/>\n                         Boston, MA  02111<br \/>\n                         Attention:  David Tobin<br \/>\n                         Facsimile:  (617) 556-8875<\/p>\n<p>                         with a copy to:<\/p>\n<p>                         Goodwin, Proctor &amp; Hoar, LLP<br \/>\n                         Exchange Place<br \/>\n                         Boston, MA  02109<br \/>\n                         Attention:  Jeffrey C. Hadden<br \/>\n                         Facsimile:   (617) 523-1231<\/p>\n<p>                (c) To any other Purchaser: The address reflected on the<br \/>\nsignature page to this Agreement or at such other address or addresses as shall<br \/>\nhave been furnished in writing by such party to the other parties to this<br \/>\nAgreement.<\/p>\n<p>                7.8 Finder&#8217;s Fee. Each party represents that it neither is nor<br \/>\nwill be obligated for any finder&#8217;s fee(s) or commission in connection with this<br \/>\ntransaction for which any other party hereto could become liable. Each Purchaser<br \/>\nagrees to indemnify and to hold harmless the Company from any liability for any<br \/>\ncommission or compensation in the nature of any finder&#8217;s fee(s) (and the costs<br \/>\nand expenses of defending against such liability or asserted liability) for<br \/>\nwhich such Purchaser or any of its officers, partners, employees, or<br \/>\nrepresentatives is<\/p>\n<p>                                       16<br \/>\n   19<\/p>\n<p>responsible. The Company has engaged Morgan Keegan as placement agent for the<br \/>\nshares of Series C Preferred Stock being sold hereunder and shall be responsible<br \/>\nfor the payment of all fees and other amounts payable to Morgan Keegan in<br \/>\nconnection therewith. The Company agrees to indemnify and hold harmless each<br \/>\nPurchaser from any liability for any commission or compensation in the nature of<br \/>\na finder&#8217;s fee(s) (and the costs and expenses of defending against such<br \/>\nliability or asserted liability) for which the Company or any of its officers,<br \/>\nemployees, or representatives is responsible.<\/p>\n<p>                7.9 Expenses. Each party shall bear its own cost and expenses<br \/>\nincurred with respect to this Agreement and the documents referred to herein<br \/>\nincluding attorney&#8217;s fees.<\/p>\n<p>                7.10 Amendments and Waivers. Any term of this Agreement may be<br \/>\namended or waived, and this Agreement may be terminated, with the written<br \/>\nconsent of the Company and Purchasers representing at least a majority of the<br \/>\noutstanding Series C Preferred Stock (or the Common Stock issuable upon<br \/>\nconversion thereof) purchased hereunder. Any amendment or waiver effected in<br \/>\naccordance with this Section 7.10 shall be binding upon the Purchasers and each<br \/>\nholder or transferee of the Series C Preferred Stock (or the Common Stock<br \/>\nissuable upon conversion thereof), each future holder of all such securities,<br \/>\nand the Company.<\/p>\n<p>                7.11 Severability. If any one or more of the provisions<br \/>\ncontained herein, or the application thereof in any circumstance, is held<br \/>\ninvalid or unenforceable in any respect for any reason, the validity, legality<br \/>\nand enforceability of any such provision in every other respect and of the<br \/>\nremaining provisions hereof shall not be in any way impaired or affected, and<br \/>\nall such remaining provisions hereof shall be enforceable in accordance with<br \/>\ntheir terms.<\/p>\n<p>                7.12 Delays or Omissions. No delay or omission to exercise any<br \/>\nright, power or remedy accruing to any holder of any of the Series C Preferred<br \/>\nStock (or the Common Stock issuable upon conversion thereof) or to the Company,<br \/>\nupon any breach or default of the Company or by any Purchaser under this<br \/>\nAgreement, shall impair any such right, power or remedy of any Purchaser or the<br \/>\nCompany, as the case may be, nor shall it be construed to be a waiver of any<br \/>\nsuch breach or default, or an acquiescence therein, or of or in any similar<br \/>\nbreach or default thereafter occurring; nor shall any waiver of any single<br \/>\nbreach or default be deemed a waiver of any other breach or default theretofore<br \/>\nor thereafter occurring. Any waiver, permit, consent or approval of any kind or<br \/>\ncharacter on the part of any Purchaser or the Company, as the case may be, of<br \/>\nany breach or default under this Agreement, or any waiver on the part of any<br \/>\nPurchaser or the Company, as the case may be, of any provisions or conditions of<br \/>\nthis Agreement, must be in writing and shall be effective only to the extent<br \/>\nspecifically set forth in such writing. All remedies, either under this<br \/>\nAgreement or by law or otherwise afforded to any holder, shall be cumulative and<br \/>\nnot alternative.<\/p>\n<p>                                       17<br \/>\n   20<br \/>\n                7.13 Entire Agreement. This Agreement, the Registration Rights<br \/>\nAgreement and the other documents referred to herein to which any Purchaser is a<br \/>\nparty constitute the entire agreement among the parties hereto pertaining to the<br \/>\nsubject matter hereof, and this Agreement supersedes all prior agreements and<br \/>\nunderstanding among the parties with respect to the subject matter hereof.<\/p>\n<p>        IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be<br \/>\nexecuted and delivered by their respective duly authorized officers or<br \/>\nrepresentatives as of the date first written above.<\/p>\n<p>                                    COMPANY:<\/p>\n<p>                                    BAM! ENTERTAINMENT, INC.<\/p>\n<p>                                    By: \/s\/ RAYMOND C. MUSCI<br \/>\n                                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                        Raymond C. Musci, President<\/p>\n<p>                                    By: \/s\/ GEORGE M. SUNDHEIM, III<br \/>\n                                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                        George M. Sundheim, III, Secretary<\/p>\n<p>                                    PURCHASERS:<\/p>\n<p>                                    PAR CAPITAL MANAGEMENT, INC.<\/p>\n<p>                                    By:  \/s\/ DAVID E. TOBIN<br \/>\n                                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                        Name:  David E. Tobin<br \/>\n                                        Title: Vice President<\/p>\n<p>                                    MORGAN KEEGAN EARLY STAGE FUND, L.P.<\/p>\n<p>                                    By: MERCHANT BANKERS, INC. as the general<br \/>\n                                        partner of Morgan Keegan Early Stage<br \/>\n                                        Fund, L.P.<\/p>\n<p>                                        By: \/s\/ MINOR PERKINS<br \/>\n                                            &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Minor Perkins<br \/>\n                                            Title: Vice President<\/p>\n<p>                                    \/s\/ RAYMOND C. MUSCI<br \/>\n                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                    Raymond C. Musci<\/p>\n<p>                                    \/s\/ ANTHONY R. WILLIAMS<br \/>\n                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                    Anthony R. Williams<\/p>\n<p>                                    \/s\/ ROBERT HOLMES<br \/>\n                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                    Robert Holmes<\/p>\n<p>                                       18<\/p>\n<p>   21<br \/>\n                                    \/s\/ STEPHEN AMBLER<br \/>\n                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                    Stephen Ambler<\/p>\n<p>                                    \/s\/ JOSEPH MORICI<br \/>\n                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                    Joseph Morici<\/p>\n<p>                                    \/s\/ MARK DYNE<br \/>\n                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                    Mark Dyne<\/p>\n<p>                                    \/s\/ KEVIN BERMEISTER<br \/>\n                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                    Kevin Bermeister<\/p>\n<p>                                    \/s\/ ANTHONY NEUMANN<br \/>\n                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                    Anthony Neumann<\/p>\n<p>                                    FIMAS, a Partnership<\/p>\n<p>                                    By:  \/s\/ GEORGE M. SUNDHEIM, III<br \/>\n                                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                         Name: George M. Sundheim, III<br \/>\n                                         Its:  General Partner<\/p>\n<p>                                    \/s\/ PAMELA COLBURN<br \/>\n                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                    Pamela Colburn<\/p>\n<p>                                    \/s\/ TERRY PHILLIPS<br \/>\n                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                    Terry Phillips<\/p>\n<p>                                    \/s\/ DAVID P. CLARK<br \/>\n                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                    David P. Clark<\/p>\n<p>                                    \/s\/ STEVEN J. MASSARSKY<br \/>\n                                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                    Steven J. Massarsky<\/p>\n<p>                                    K&amp;L 2000 LLC<\/p>\n<p>                                    By:  \/s\/ PAUL W. SWEENEY, JR.<br \/>\n                                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                         Name:  Paul W. Sweeney, Jr.<br \/>\n                                         Title: Admin. Partner &#8212; LA<\/p>\n<p>                                       19<br \/>\n   22<\/p>\n<p>                                    EXHIBIT A<\/p>\n<p>        Form of Second Amended and Restated Certificate of Incorporation<\/p>\n<p>                                       i<br \/>\n   23<\/p>\n<p>                                    EXHIBIT B<\/p>\n<p>                          Registration Rights Agreement<\/p>\n<p>                                       ii<br \/>\n   24<\/p>\n<p>                                    EXHIBIT C<\/p>\n<p>            Form of Proprietary Information and Inventions Agreement<\/p>\n<p>                                      iii<br \/>\n   25<\/p>\n<p>                                    EXHIBIT D<\/p>\n<p>                              Bylaws of the Company<\/p>\n<p>                                       iv<br \/>\n   26<\/p>\n<p>                                    EXHIBIT E<\/p>\n<p>                    Form of Opinion of Counsel to the Company<\/p>\n<p>                                       v<br \/>\n   27<\/p>\n<p>                                    EXHIBIT F<\/p>\n<p>                  Co-Sale and Right of First Refusal Agreement<\/p>\n<p>                                       vi<br \/>\n   28<\/p>\n<p>                                   SCHEDULE 1<\/p>\n<p>                             Schedule of Purchasers<\/p>\n<table>\n<caption>\n                                                   NUMBER OF SHARES OF               PURCHASE<br \/>\n           PURCHASER                             SERIES C PREFERRED STOCK             PRICE<br \/>\n           &#8212;&#8212;&#8212;                             &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;           &#8212;&#8212;&#8212;-<br \/>\n<s>                                              <c>                                <c><br \/>\nPAR Capital Management, Inc.                              88,680                    $2,000,000<\/p>\n<p>Raymond C. Musci                                          13,302                    $  300,000<\/p>\n<p>Anthony R. Williams                                       13,302                    $  300,000<\/p>\n<p>Morgan Keegan Early Stage Fund, L.P.                      88,680                    $2,000,000<\/p>\n<p>Robert Holmes                                              6,651                    $  150,000<\/p>\n<p>Stephen Ambler                                             1,109                    $   25,000<\/p>\n<p>Joseph Morici                                                887                    $   20,000<\/p>\n<p>Mark Dyne                                                  4,434                    $  100,000<\/p>\n<p>Kevin Bermeister                                           4,434                    $  100,000<\/p>\n<p>K &amp; L 2000 LLC                                             1,109                    $   25,000<\/p>\n<p>Pam Colburn                                                1,109                    $   25,000<\/p>\n<p>Anthony Neumann                                            1,109                    $   25,000<\/p>\n<p>Terry Phillips                                            13,302                    $  300,000<\/p>\n<p>Steve Massarsky                                            2,217                    $   50,000<\/p>\n<p>David Clark                                                4,434                    $  100,000<\/p>\n<p>FIMAS, L.P., a Partnership                                   900                    $   20,297.70<\/p>\n<p>TOTAL                                                    245,659                    $5,540,297.70<br \/>\n<\/c><\/c><\/s><\/caption>\n<\/table>\n<p>                                      vii<br \/>\n   29<\/p>\n<p>                                 SCHEDULE 2.2(a)<\/p>\n<p>                        Contingent Reserved Common Shares<\/p>\n<table>\n<s>                                           <c><br \/>\nFranchise Films, Inc.                         131,625<br \/>\nSpyglass Entertainment Group, L.P.            100,000<br \/>\n<\/c><\/s><\/table>\n<p>                                      viii<br \/>\n   30<\/p>\n<p>                                 SCHEDULE 2.2(d)<\/p>\n<p>                      Stockholders and Option Holders List<\/p>\n<table>\n<s>                                                               <c><br \/>\nCOMMON STOCKHOLDERS<\/p>\n<p>Raymond C. Musci                                                  123,609<br \/>\nRobert E. Lloyd                                                     9,750<br \/>\nTracy Ann Sebastian                                                 9,750<br \/>\nPhilip L. Rosenberg                                                 9,750<br \/>\nRobert Holmes                                                      32,224<br \/>\nGary Nemetz                                                         9,750<br \/>\nD&amp;S Partners, a California General Partnership                      9,750<br \/>\nAnthony R. Williams                                                89,897<br \/>\nKevin Bermeister                                                    3,656<br \/>\nMark Dyne                                                           3,656<br \/>\nElie Samaha                                                         7,312<br \/>\nFIMAS, L.P., a Partnership                                          3,656<br \/>\nFranchise Films, Inc.                                              14,625<\/p>\n<p>PREFERRED SERIES A STOCKHOLDERS<\/p>\n<p>Raymond C. Musci                                                  482,625<br \/>\nAnthony R. Williams                                               351,000<br \/>\nRobert Holmes                                                      87,750<br \/>\nKevin Bermeister                                                   10,969<br \/>\nMark Dyne                                                          10,969<br \/>\nElie Samaha                                                        21,938<br \/>\nFIMAS, L.P., a Partnership                                         10,969<\/p>\n<p>PREFERRED SERIES B STOCKHOLDERS<\/p>\n<p>PAR Capital Management, Inc                                       198,301<br \/>\nRaymond C. Musci                                                   28,329<br \/>\nAnthony R. Williams                                                28,329<br \/>\nMorgan Keegan Early Stage Fund, L.P.                               22,092<br \/>\nRobert Holmes, Jr                                                  11,332<br \/>\nMorgan Keegan Employee Investment Fund, L.P.                        6,237<\/p>\n<p>OPTION HOLDERS<\/p>\n<p>Robin Cairns                                                        2,500<br \/>\nAaron Endo                                                          7,500<br \/>\nLynnie Nojadera                                                     3,500<br \/>\nJoe Morici                                                          5,000<br \/>\nHideo Oishi                                                         5,000<br \/>\n<\/c><\/s><\/table>\n<p>                                       ix<br \/>\n   31<\/p>\n<table>\n<s>                                        <c><br \/>\nMark Dyne                                   4,000<br \/>\nRobert Holmes                               4,000<br \/>\nRobert Lloyd                                4,000<br \/>\nScott Smith                                 1,250<br \/>\nGeorge M. Sundheim, III                     4,000<br \/>\nSherri Zook                                 2,500<br \/>\nJoe Booth                                   6,000<br \/>\nLisa Cheney Bolcato                         4,500<br \/>\nPierson Lippard                             4,000<br \/>\nMatt Wilkinson                              4,000<br \/>\nSamuel Allen                                2,500<br \/>\nPete Johnson                                2,500<br \/>\nKevin Watts                                 2,500<br \/>\nRichard Coles                               1,250<br \/>\nPaul Hodge                                  1,250<br \/>\nKarl D&#8217;Costa                                1,250<br \/>\nMark Harris                                 1,250<br \/>\nMikel Barron Bilbao                         1,250<br \/>\nRachel Segens                               1,250<br \/>\nCharlie Hasdell                             1,250<br \/>\nJake Noakes                                 1,250<br \/>\nThomas Woodley                              1,250<br \/>\nDoug Day                                    1,250<br \/>\nMichael Jacobsen                            1,250<br \/>\nJeff Pena                                   2,500<br \/>\nStephen Ambler                             12,750<br \/>\nSusan Kramer                                2,500<br \/>\nDavid Blundell                              1,250<br \/>\nMatthew Cooling                             1,250<br \/>\nMarcus Fielding                             1,250<br \/>\nAnne-Christine Gasc                         1,250<br \/>\nJames Hawkins                               1,250<br \/>\nCiaran Rooney                               1,250<br \/>\nMagnolia Tsele                              1,250<br \/>\nAndrew Williams                             1,250<\/p>\n<p>WARRANT HOLDERS<\/p>\n<p>PAR Capital                                30,000<br \/>\nK &amp; L 2000                                 10,000<br \/>\n<\/c><\/s><\/table>\n<p>                                       x<br \/>\n   32<\/p>\n<p>                                  SCHEDULE 2.3<\/p>\n<p>                                  Subsidiaries<\/p>\n<p>BAM Studios (Europe) Ltd.<\/p>\n<p>        2 shares issued to BAM! Entertainment Limited (1 Pound Sterling) per<br \/>\nshare<\/p>\n<p>BAM Entertainment Ltd.<\/p>\n<p>        2 shares issued to BAM! Entertainment, Inc. (1 Pound Sterling) per share<\/p>\n<p>                                       xi<br \/>\n   33<\/p>\n<p>                                  SCHEDULE 2.7<\/p>\n<p>                                   Litigation<\/p>\n<p>In a letter dated May 21, 2001, Nintendo of North America and Spike Co., Ltd.<br \/>\nreceived a letter from counsel to World Wrestling Federation Entertainment, Inc.<br \/>\n(&#8220;WWFE&#8221;) claiming a yet to be released game &#8220;Fire ProWrestling&#8221; (the &#8220;Game&#8221;)<br \/>\nviolated certain WWFE intellectual property rights and demanding that each of<br \/>\nthem cease the US distribution of the Game. The Company, which holds the rights<br \/>\nto the US version of the Game, believes that the Game slated for sale in North<br \/>\nAmerica does not violate WWFE&#8217;s rights as the US version does not contain<br \/>\nreferences to the characters, moves or wrestling organizations mentioned in the<br \/>\nletter.<\/p>\n<p>                                      xii<br \/>\n   34<\/p>\n<p>                                 SCHEDULE 2.8(a)<\/p>\n<p>                         Material Intellectual Property<\/p>\n<p>Trademark application attached.<br \/>\nList of attached agreements.<\/p>\n<p>                                      xiii<br \/>\n   35<\/p>\n<p>                                 SCHEDULE 2.8(b)<\/p>\n<p>                              Certain IP Agreements<\/p>\n<p>PowerPuff Girls license with Warner Brothers (8\/16\/00 &#8212; 8\/16\/03)<br \/>\nSports Illustrated, Inc. for Kids with Time (7\/12\/00)<br \/>\nFranchise Films Output Agreement (4\/7\/00 &#8212; 4\/7\/03)<br \/>\nSpyglass Entertainment Group, L.P. Output Agreement (10\/1\/00 &#8212; 10\/1\/05)<\/p>\n<p>                                      xiv<br \/>\n   36<\/p>\n<p>                                  SCHEDULE 2.10<\/p>\n<p>                                   Agreements<\/p>\n<p>List of agreements attached.<\/p>\n<p>                                       xv<br \/>\n   37<\/p>\n<p>                                SCHEDULE 2.10(b)<\/p>\n<p>                             Non-binding Agreements<\/p>\n<p>See attached list.<\/p>\n<p>                                      xvi<br \/>\n   38<\/p>\n<p>                                  SCHEDULE 2.11<\/p>\n<p>                                   Liabilities<\/p>\n<p>None.<\/p>\n<p>                                      xvii<br \/>\n   39<\/p>\n<p>                                  SCHEDULE 2.13<\/p>\n<p>                                    Conflicts<\/p>\n<p>Directors:<\/p>\n<p>        Mark Dynes: Chairman &amp; CEO of Brilliant Digital Entertainment (BDE &#8211;<br \/>\nAMEX), beneficial owner of roughly 8% of the common stock outstanding, owns<br \/>\nand\/or controls roughly 40% of Infogrames\/OziSoft, a video game distributor in<br \/>\nAustralia; also holds approximately 2% of Titus.<\/p>\n<p>        Robert Holmes: GBA, LLC &#8211; managing member of investment venture into<br \/>\nRipcord, some Southpeak; PCH, LLC &#8211; managing member investment venture;<br \/>\nEntertainment Brands, Inc. &#8211; Director, shareholder; Ripcord Games Director,<br \/>\nshareholder (1\/3); Northport Ventures &#8211; venture company; Acclaim Entertainment &#8211;<br \/>\ncontractual representatives and stock; Take Two &#8211; stock remaining from early<br \/>\nprivate placement; Business Incubation Group no current conflict, (some emulator<br \/>\nproposals that involve Raymond C. Musci); iBuyline, Inc. &#8211; ESD company sold to<br \/>\naggregator; NTN communications &#8211; shareholder &#8211; mini games and wireless.<\/p>\n<p>        Raymond C. Musci: Director of Brilliant Digital Entertainment.<\/p>\n<p>                                     xviii<br \/>\n   40<\/p>\n<p>                                  SCHEDULE 2.17<\/p>\n<p>                             Employee Benefit Plans<\/p>\n<p>BAM! 401(k) Plan Summary Plan Description attached.<\/p>\n<p>U.K. Employees are not entitled to participate in the BAM! 401(K) Plan, but an<br \/>\nequivalent European pension plan is planned.<\/p>\n<p>                                      xix<br \/>\n   41<\/p>\n<p>                                  SCHEDULE 2.24<\/p>\n<p>                              Financial Statements<\/p>\n<p>Financial Statements attached.<\/p>\n<p>                                       xx<br \/>\n   42<\/p>\n<p>                                SCHEDULE 2.25(d)<\/p>\n<p>                          Changes; Contracts\/Agreements<\/p>\n<p>First Amendment to Master Purchase Order Assignment Agreement (attached).<\/p>\n<p>Second Amendment to Master Purchase Order Assignment Agreement (attached).<\/p>\n<p>Third Amendment to Master Purchase Order Assignment Agreement (attached).<\/p>\n<p>Warner Bros. License Agreement #12177-PPG (Powerpuff Girls)-Amendment #1<br \/>\n(attached).<\/p>\n<p>                                      xxi<br \/>\n   43<\/p>\n<p>                                SCHEDULE 2.25(e)<\/p>\n<p>                Changes; Compensation\/Agreements with employees,<br \/>\n          representatives, agents, officers, directors or stockholders<\/p>\n<p>Changes to compensation arrangement or agreement with any employee,<br \/>\nrepresentative, agents, officer, director or stockholder attached.<\/p>\n<p>                                      xxii<br \/>\n   44<\/p>\n<p>                                SCHEDULE 2.25(i)<\/p>\n<p>                            Changes; Loans\/Guarantee<\/p>\n<p>Comerica loan documents attached.<\/p>\n<p>                                     xxiii<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[6843],"corporate_contracts_industries":[9513],"corporate_contracts_types":[9622,9627],"class_list":["post-43599","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-bam-entertainment-inc","corporate_contracts_industries-technology__software","corporate_contracts_types-planning","corporate_contracts_types-planning__purchase"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43599","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43599"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43599"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43599"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}